Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
View Issue
View Supplement
In This Issue
The latest research findings from the 18th annual meeting of the American Glaucoma Society.
Geoffrey T. Emerick, MD
Five surgeons explain their preferences.
Cynthia Mattox, MD; Thomas W. Samuelson, MD; Geoffrey T. Emerick, MD; Garry P. Condon, MD; and Alan L. Robin, MD
Amish B. Doshi, MD; Kouros Nouri-Mahdavi, MD, MS; Sunil Deokule, MBBS, MS; Rigby Slight, MD; and Robert N. Weinreb, MD
Do we need a new definition for successful outcomes?
Robert J. Noecker, MD, MBA
The potential role of this technology in glaucoma.
Michelle L. Gabriele, BSc; Gadi Wollstein, MD; and Joel S. Schuman, MD
Rachel Niknam, MD, and Eydie Miller-Ellis, MD
Combigan is an effective adjunct to prostaglandin analogs that spares patients the hassle of administering three drugs separately.
E. Randy Craven, MD
What might be coming to a pharmacy near you?
Gary D. Novack, PhD
Malik Y. Kahook, MD, and Robert J. Noecker, MD, MBA
Tips for integrating research studies into busy daily schedules.
Diana Hatsis, RN, BSN Hons, COT
Dr. Brandt shares his approach to communicating with patients and his outlook for the future.
James D. Brandt, MD
Richard A. Lewis, MD, Chief Medical Editor
Subscribe
Stay up to date all on all things Glaucoma by signing up to receive our print publication or subscribe to our email alerts.